History Teaches Us That Confronting Antibiotic Resistance Requires Stronger Global Collective Action

Journal of Law, Medicine and Ethics

Volumn 43, Issue S3, 2015, Pages 27-32

  Podolsky, Scott H ^a   Bud, Robert ^b   Gradmann, Christoph ^c   Hobaek, Bård ^c   Kirchhelle, Claas ^d   Mitvedt, Tore ^e   Santesmases, María Jesús ^f   Thoms, Ulrike ^g   Berild, Dag ^h   Kveim Lie, Anne ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SCIENCE MUSEUM   (United Kingdom)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e KAROLINSKA INSTITUTE   (Sweden)

^f CSIC   (Spain)

^g MAX PLANCK INSTITUTE FOR THE HISTORY OF SCIENCE   (Germany)

^h UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; HEALTH; HEALTH CARE POLICY; HUMAN; INTERNATIONAL COOPERATION; MANAGEMENT;

DRUG RESISTANCE, MICROBIAL; GLOBAL HEALTH; HEALTH POLICY; HUMANS; INTERNATIONAL COOPERATION; POLICY MAKING;

EID: 84938601308     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/jlme.12271     Document Type: Article

References (23)

1. R. Bud, Penicillin: Triumph and Tragedy (New York: Oxford University Press, 2007).
2. L. W. Batten, "Discussion on the Use and Abuse of Antibiotics, " Proceedings of the Royal Society of Medicine 48 (1955): 355-364.
3. E. Jawetz and M. S. Marshall, "The Role of the Laboratory in Antibiotic Therapy, " Journal of Pediatrics 37, no. 4 (1950): 545-554.
4. E. Jawetz, "Patient, Doctor, Drug, and Bug, " Antibiotics Annual (1957-1958): 287-295.
5. S. H. Podolsky, The Antibiotic Era: Reform, Resistance, and the Pursuit of a Rational Therapeutics (Baltimore: Johns Hopkins University Press, 2015): at 43-87.
6. S. Temko, oral arguments "In the Matter of Novobiocin-Tetracycline Drugs; Calcium Novobiocin-Sulfamethizole Tablets (Upjohn Co.), Arlington, VA, August 13, 1969, " Box 88-78-36, FDA Division of Dockets Management, Rockville, Maryland.
7. Negotiations of the Storting (Norwegian Parliament): Ot.prp.51 1928; Ot.prp.50 1938.
8. M. Andrew, B. Jøldal, and G. Tomson, "Norway's National Drug Policy. Its Evolution and Lessons for the Future, " Development Dialogue 1 (1995): 25-53.
9. A. Kveim Lie, "Producing Standards, Producing the Nordic Region: Antibiotic Susceptibility Testing, from 1950-1970, " Science in Context 27, no. 2 (2014): 215-248.
10. "Meetings of the Director of Health and His Expert Council, " 4/22/47, 6/27/47, Archives of the Norwegian Medicines Agency.
11. U. Thoms, "Between Promise and Threat: Antibiotics in Food in Germany 1950-1980, " NTM. Zeitschrift für Geschichte der Wissenschaften, Technik und Medizin 20, no. 3 (2012): 181-214.
12. C. Kirchhelle, Pyrrhic Progress. Antibiotics in Western Food Production (1949-2013), Ph.D. Thesis, Oxford University (forthcoming).
13. A. So et al., "One Health Perspective: An Integrated Systems Approach Is Needed to Ensure the Sustainability of Antibiotic Effectiveness for Both Humans and Animals, " Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): available via aslme.org.
14. M. J. Santesmases, "Distributing Penicillin: The Clinic, the Hero and Industrial Production in Spain, 1943-1952, " in V. Quirke and J. Slinn, eds., Perspectives on Twentieth-Century Pharmaceuticals (Oxford: Peter Lang, 2010).
15. "Report to the Director-General, Scientific Group on Antibiotics Research, Geneva, 26-30 May 1959, " Box 10, ff 6, Selman Waksman papers, Rutgers University.
16. C. Gradmann, "Sensitive Matters: The World Health Organization and Antibiotic Resistance Testing, 1945-1975, " Social History of Medicine 26, no. 3 (2013): 555-574.
17. T. Watanabe, "Infective Heredity of Multiple Drug Resistance in Bacteria, " Bacteriological Reviews 27 (1963): 87-115
18. J. A. Osmundsen, "Are Germs Winning the War against People?" Look (October 18, 1966): 140-141.
19. S. B. Levy, R. C. Clowes, and E. L. Koenig, eds., Molecular Biology, Pathogenicity, and Ecology of Bacterial Plasmids (New York: Plenum, 1981).
20. J. Lederberg and R. E. Shope, eds., Emerging Infections: Microbial Threats to Health in the United States (Washington, D.C.: National Academy Press, 1992).
21. C. Gradmann, "Re-Inventing Infectious Disease: Antibiotic Resistance and Drug Development at the Bayer Company 1945-1980, " Medical History 60, no. 2 (forthcoming 2016).
22. World Health Organization, WHO Global Strategy for Containment of Antibiotic Resistance (Geneva: World Health Organization, 2001).
23. World Health Organization, Antimicrobial Resistance: Global Report on Surveillance (Geneva: World Health Organization, 2014).